6,6'-methylenebis(2,2-dimethyl-4-methanesulfonic acid-1,2-dihydroquinoline) has been researched along with Disease Models, Animal in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Csabina, S; Furka, I; Hauck, M; Kovács, J; Mikó, I; Petö, K; Schmidt, E; Tóth, G; Varga, A | 1 |
| Mezey, B; Pollák, Z; Röth, E; Temes, G; Török, B; Tóth, K | 1 |
2 other study(ies) available for 6,6'-methylenebis(2,2-dimethyl-4-methanesulfonic acid-1,2-dihydroquinoline) and Disease Models, Animal
| Article | Year |
|---|---|
Protection of the renal artery in nephron-sparing surgery. II. Arterial contractility investigations.
Topics: Animals; Antioxidants; Constriction; Disease Models, Animal; Dogs; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Hypertonic Solutions; Hypothermia, Induced; Ischemia; Kidney; Male; Nephrons; Norepinephrine; Organ Preservation Solutions; Quinolines; Renal Artery; Reperfusion Injury; Time Factors; Vasoconstriction; Vasoconstrictor Agents | 1997 |
Promising reduction of ventricular fibrillation in experimentally induced heart infarction by antioxidant therapy.
Topics: Animals; Antioxidants; Disease Models, Animal; Dogs; Electrocardiography; Heart; Myocardial Infarction; Quinolines; Ventricular Fibrillation | 1987 |